Research graph
References from Ocular haemorrhages under antithrombotic therapy: risk factors, management and clinical perspectives. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1007/s10354-017-0577-z
10.1007/s10354-017-0577-z · 2018 · External reference
Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
10.1378/chest.11-2295 · 2012 · External reference
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
10.1016/s0140-6736(13)62343-0 · 2014 · External reference
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
10.1016/s0140-6736(04)16721-4 · 2004 · External reference
Risk of substantial intraocular bleeding with novel Oral anticoagulants: systematic review and meta-analysis
10.1001/jamaophthalmol.2015.0985 · 2015 · External reference
Edoxaban versus warfarin in patients with atrial fibrillation
10.1056/nejmoa1310907 · 2013 · External reference
Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
10.1136/bmj.j510 · 2017 · External reference
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial
10.1016/s0140-6736(12)60986-6 · 2012 · External reference
Effect of home testing of international normalized ratio on clinical events
10.1056/nejmoa1002617 · 2010 · External reference
Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study
10.1161/circulationaha.113.002283 · 2013 · External reference
The reversal of anticoagulation in clinical practice
10.7861/clinmedicine.18-4-314 · 2018 · External reference
The prevalence of adverse ocular Hemorrhagic events in patients utilizing Oral anticoagulant and antiplatelet therapy in routine clinical practice
10.3928/23258160-20171215-04 · 2018 · External reference
Vitreous hemorrhage – causes, diagnosis, and management
10.4103/ijo.ijo_928_22 · 2023 · External reference
Dabigatran versus warfarin in the treatment of acute venous thromboembolism
10.1056/nejmoa0906598 · 2009 · External reference
Heparin and low-molecular-weight heparin: the seventh ACCP conference on antithrombotic and thrombolytic therapy
10.1378/chest.126.3_suppl.188s · 2004 · External reference
Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies
10.1001/archinte.162.16.1833 · 2002 · External reference
Direct oral anticoagulants: new drugs and new concepts
10.1016/j.jcin.2014.06.014 · 2014 · External reference
Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19
10.1001/archopht.1995.01100090070025 · 1995 · External reference
Vitrectomy in the management of diabetic retinopathy
10.1016/s0039-6257(99)00036-3 · 1999 · External reference
Displacement of submacular hemorrhage secondary to age-related macular degeneration with subretinal injection of air and tissue plasminogen activator
10.1038/s41598-022-26289-6 · 2022 · External reference
2021 European heart rhythm association practical guide on the use of non-vitamin K antagonist Oral anticoagulants in patients with atrial fibrillation
10.1093/europace/euab065 · 2021 · External reference
Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
10.1378/chest.11-2298 · 2012 · External reference
Outcomes and predictors of very stable INR control during chronic anticoagulation therapy
10.1182/blood-2009-02-207928 · 2009 · External reference
Platelet transfusion: a clinical practice guideline from the AABB
10.7326/m14-1589 · 2015 · External reference
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro heart survey
10.1378/chest.10-0134 · 2010 · External reference
2020 ACC expert consensus decision pathway on Management of Bleeding in patients on Oral anticoagulants: a report of the American College of Cardiology Solution set Oversight Committee
10.1016/j.jacc.2020.04.053 · 2020 · External reference
Safety of recombinant activated factor VII in randomized clinical trials
10.1056/nejmoa1006221 · 2010 · External reference
Idarucizumab for dabigatran reversal – full cohort analysis
10.1056/nejmoa1707278 · 2017 · External reference
Andexanet alfa for acute major bleeding associated with factor Xa inhibitors
10.1056/nejmoa1607887 · 2016 · External reference
